Over-expression of p53 and mutations in the p53 gene are more frequent in poorly differentiated and anaplastic carcinomas than in well-differentiated papillary and follicular carcinomas [32,54,63]. This evidence concerns the gene TP53 and thyroid gland follicular carcinoma.